Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 8

API Holdings Pvt Ltd – PharmEasy Business Segment

Group - 8
Roll no Name
21-F-208 Kedar Bivalkar
21-F-228 Iris Dsouza
21-F-238 Cherylann Gomes
21-F-248 Chaitanya Kadam
21-F-258 Mangesh Kulkarni
21-F-308 Pankaj Marye
21-F-318 Aishwarya Narvankar
21-F-328 Rupali Raut
21-F-338 Mitesh Shah
21-F-348 Ashwini Shinde
PharmEasy is a consumer healthcare that provides consumers with on-demand, home
delivered access to a wide range of prescription, OTC pharmaceutical, other consumer
healthcare products, comprehensive diagnostic test services, and teleconsultations thereby
serving their healthcare needs.
Competitors in the Market

• 1mg
• Practo
• NetMeds
• ApolloPharmacy

Competitors comparison between PharmEasy and 1mg

Business Model PharmEasy 1mg


Target Market Chronic care segment Males and females above 35 Fitness consumer—20-30-year-old
years and the others such as the influencers. consumers, largely male and patients
who buy prescribed supplements.
Value Added Services A convenient and easy way to buy medicines and A convenient and easy way to buy
delivered at doorstep. Cheaper medicines as medicines and delivered at doorstep.
compared to the medical stores. Dosage reminders Free sample collection from home for lab
Discounts and cashback on medicines. tests and diagnostics. Consultation with
qualified doctors online without the
need to visit the clinic
Revenue Streams Sponsored Listing Advertisements Commissions Lab and diagnostic tests Online medicine
from the sale from drugs and health equipment order delivery Doctor consultation
Lab and diagnostic tests Healthcare Partnerships Subscription-
based care plan
Net Worth/Valuation (Crores) 5729 241.4
Gender distribution

40.81
Market Analysis as on FY23 (% wise)
59.19

Male Female

Age Distribution
40 36.97
35
30
24.47
25
20 17.18
15
9.41
10 6.93
5.04
5
0
18-24 25-34 35-44 45-54 55-64 65+

Age Distribution
PharmEasy: Financial Snapshot
FY21 FY22
8491
5729

2335 2981

-641 -814
-2731 -2589
O pe r ati ng Re ve nu e T ot al Expe ns e s P r ofi l /Loss C as h f r om O ps

PharmEasy Revenue Breakdown


Particulars FY21 FY22

Employee Benefit Expenses 270.30 1459.00 27.7 418 81.1


26
Advertising & Promotion
135.00 494.00
Exp.
COGS 2152.00 5113.00 FY21 FY22

EBITDA Margin -22.61% -39.66%


2282
5230
Expense/Rs. Of Op. Revenue Rs. 1.28 Rs. 1.48
Sale of Products Sale of Services Other Operating Revenue
ROCE -14.42% -32.11%

You might also like